A Phase I/II, Open-Label Study of ADXS-503 Alone and in Combination with Pembrolizumab in Subjects with Metastatic Squamous or Non-Squamous Non-Small Cell Lung Cancer

Brief Summary

Type:
Lung Cancers

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT03847519

Study #:
STUDY00145284

Start Date:
Sep 29, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03847519

View Complete Trial Details & Eligibility at ClinicalTrials.gov